Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis

Cell Res. 2025 Jan 9. doi: 10.1038/s41422-024-01068-2. Online ahead of print.
No abstract available

Publication types

  • Letter